19th May 2009 17:59
RNS Number : 5318S
AGI Therapeutics plc
19 May 2009
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 18 May 2009 that BIAM Limited had decreased its shareholding to 2,550,795 Ordinary Shares representing 3.78% of AGI's Issued Share Capital.
On 19 May 2009 AGI was notified that BIAM Limited no longer had a notifiable interest in AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai